BIOSTART's vision is to provide a full range of unmatched, professional, experience-based, tailored-to-client-needs advice, services and support, at an affordable price, minimizing risk, time-to-market and cost, whilst increasing chance of success and patient access to new revolutionary drugs, devices and digital health solutions.
BIOSTART's 16-years of success are the result of its strict adherence to four key operating values:
Excellence: Sourcing and securing the best people for each project.
Quality output: working to predefined goals and standards.
Results driven: generating the agreed output on time.
Efficiency:
cost effectively providing what is needed.
BIOSTART operates according to a unique business model: By limiting the size of its highly experienced ‘in-house’ team and harnessing the expertise of its large global network of "specialist" BIOSTART Associates, using their services
only when they are needed, BIOSTART is able to provide its customers with unmatched professional support, at an affordable price.
With its first client in 1999, and officially founded in 2002,
BIOSTART has served small, mid-sized and ‘in trouble’ companies in Europe, the USA, South America, Asia, the Middle East and Africa.
BIOSTART has worked on ‘bringing to market’ a wide range of cutting-edge-technology-based products and services, covering most therapeutic areas. Examples include:
TYPE | DESCRIPTION |
---|---|
Drugs & Vaccines | Small molecules & biologics Personalized medicines Prophylactic & therapeutic vaccines |
Diagnostics | Companion, point of care & digital health Imaging media & hardware (single and multi-modal) |
Treatment Devices | Invasive & non-invasive Robotics & bioelectric therapy |
R&D Services | Wide variety of preclinical services Biomarkers & R&D tools Drug delivery systems |
Registered name: BIOSTART Consulting GmbH
Registration No.: CH-020.4.041.005-4
Country of registration: Switzerland